Kasra Rezaei, MD

Medical School: Azad University, Tehran, Iran, 2001   

Internship: General Surgery, Vanderbilt University, 2009

Residency: Vanderbilt Eye Institute, Vanderbilt University, 2012

Fellowship: Vitreo-Retinal Fellowship, Associated Retina Consultants, 2014

Board Certification: American Board of Ophthalmology, 2014         

Memberships: American Academy of Ophthalmology (AAO)

Subspecialty memberships: The American Society of Retina Surgeons

Dr. Rezaei completed his vitreoretinal fellowship at the Associated Retina Consultants in Phoenix, Arizona. He performed his residency at the Department of Ophthalmology, Vanderbilt University. Dr. Rezaei has an extensive research background in macular degeneration from both the University of Chicago and Vanderbilt University. His research has resulted in publications in prestigious peer-reviewed journals and was presented at national meetings.

Dr. Rezaei’s clinical interests include the management of complex retinal detachments, diabetic retinopathy, retinal vascular occlusions, and age-related macular degeneration. In addition to his interest in taking care of patients and medical research, Dr. Rezaei is an avid athlete and has finished multiple marathons in the past few years.

Eye Institute at Harborview

Location: 908 Jefferson St., 7th Floor Seattle, WA Clinic Phone: 206-744-2020 Clinic Fax: 206-520-9310 Mailing Address: Box 359608 325 Ninth Ave. Seattle, WA 98104 Academic Phone: 206-543-7250

‘’It is a great honor to participate in the care of patients and improve their vision and quality of life."

2010                 Selected to attend the 5th annual Heed Foundation Resident’s Retreat

2006                 Illinois Society to Prevent Blindness Research Grant

2005                 Illinois Society to Prevent Blindness Research Grant

Dr. Rezaei’s clinical interests include the management of complex retinal detachments, diabetic retinopathy, retinal vascular occlusions, and age-related macular degeneration.

Dr. Rezaei’s research includes the development of a new generation of optical coherence tomography in the diagnosis of diabetic retinopathy, age-related macular degeneration, and vein occlusion.